Walder Wyss advised the funds managed by OrbiMed Advisors LLC on the deal. vVARDIS, a Swiss high growth dental company, and OrbiMed, a leading healthcare investment...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Versant Ventures and OrbiMed on the transaction. Helicore Biopharma, a biopharmaceutical company focused on the discovery and development of first-in-class...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised an affiliate of OrbiMed Advisors on the transaction. OrbiMed Advisors announced its agreement to purchase 100% of Neurelis Inc.’s rights, royalty interests,...
You must be a Standard 1 Year member to access this content.
OrbiMed was advised by LPA-CGR, BCLP, and Covington & Burling. Dechert LLP (Paris and New York) advised Poxel. OrbiMed announced it has entered into a non-dilutive...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented OrbiMed on the transaction. OrbiMed announced it has raised more than $4.3 billion in commitments for its latest private investment...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
You must be a Standard 1 Year member to access this content.
Covington advised OrbiMed on the deal. An investment fund affiliated with OrbiMed Advisors announced a $75 million delayed draw senior secured loan to be provided to...
You must be a Standard 1 Year member to access this content.
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
You must be a Standard 1 Year member to access this content.
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
You must be a Standard 1 Year member to access this content.
Bryan Cave Leighton Paisner (BCLP) has advised two U.S. healthcare investment funds, Orbimed Advisors and Deerfield Management Company. Valneva was advised in France by Hogan Lovells...
You must be a Standard 1 Year member to access this content.
IndusLaw advised Orbimed on the deal, while Lakshmikumaran & Sridharan advised LifeCell International. Orbimed announced its investment of Approx. $30 million in Lifecell International. LifeCell International Private...
You must be a Standard 1 Year member to access this content.
